106 related articles for article (PubMed ID: 768904)
1. [Adriamycin, VM 26, cyclophosphamide and prednisone (AVmCP) combination in the therapy of disseminated lymphoreticulosarcoma (Stages or topographical forms III and IV].
Misset JL; Pouillart P; Amiel JL; Schwarzenberg L; Hayat M; de Vassal F; Musset M; Belpomme D; Jasmin C; Albahary C; Depierre R; Mathé G
Nouv Presse Med; 1975 Dec; 4(44):3117-20. PubMed ID: 768904
[TBL] [Abstract][Full Text] [Related]
2. [Combination of adriamycin, VM 26, cyclophosphamide and prednisone in the treatment of hematosarcomas].
Laurens A; Thevenot J; Charron D; Jorry F; Dumonchel P; Martola R
Ann Med Interne (Paris); 1977 May; 128(5):493-6. PubMed ID: 334012
[No Abstract] [Full Text] [Related]
3. [Adriamycin for the treatment of non HOdgkin's lymphomas (author's transl)].
Parlier Y; Gorin NC; Stachowiak J; Najman A; Duhamel G
Sem Hop; 1981 Nov 8-25; 57(41-42):1685-90. PubMed ID: 6272402
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with adriamycine, VM 26, cyclophosphamide and prednisone in lymphosarcoma and reticulosarcoma stage III and IV.
Misset JL; Pouillart P; Belpomme D; Schwarzenberg L; Delgado M; Gil M; Jasmin C; Hayat M; Mathe G
Eur J Cancer (1965); 1977; 13(4-5):411-4. PubMed ID: 326554
[No Abstract] [Full Text] [Related]
5. [4-year-observation of results of VM 26 treatment of pathologic syndromes from the lymphoma malignum group].
Lawkowicz W; Polubiec A; Domańska B
Acta Haematol Pol; 1975; 6(2):143-7. PubMed ID: 1098351
[TBL] [Abstract][Full Text] [Related]
6. Non-Hodgkin's malignant lymphomata in adults: chemo-radiotherapy in stages III and IV.
Pouillart P; Hayat M; Schwarzenberg L; Amiel JL; Mathé G; Tubiana M
Br J Cancer Suppl; 1975 Mar; 2():505-11. PubMed ID: 52369
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup.
Anderson T; Bender RA; Fisher RI; DeVita VT; Chabner BA; Berard CW; Norton L; Young RC
Cancer Treat Rep; 1977 Sep; 61(6):1057-66. PubMed ID: 71205
[No Abstract] [Full Text] [Related]
8. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
9. [Cyclophosphamide-vincristine-prednisone combination in the treatment of lympho- and reticulosarcomas in adults (60 cases)].
Gorin NC; David R; Stachowiak J; Najman A; Duhamel G
Nouv Presse Med; 1976 Nov; 5(38):2525-30. PubMed ID: 790316
[TBL] [Abstract][Full Text] [Related]
10. Plasma glutathione S-Transferase P1-1 as a prognostic factor in patients with advanced non-Hodgkin's lymphoma (stages III and IV).
Katahira T; Takayama T; Miyanishi K; Hayashi T; Ikeda T; Takahashi Y; Takimoto R; Matsunaga T; Kato J; Niitsu Y
Clin Cancer Res; 2004 Dec; 10(23):7934-40. PubMed ID: 15585627
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of inoperable glioblastomas using a combination of adriamycin, VM 26 and CCNU].
Pouillart P; Mathé G; Huguenin P; M'orin P; Poisson M; Buge A; Palangie T; Parrot R
Bull Cancer; 1977; 64(1):125-36. PubMed ID: 193597
[TBL] [Abstract][Full Text] [Related]
12. Synchronization recruitment chemotherapy in non-Hodgkin hematosarcomas.
Schneider M; Mancini G; Fella C; Aubanel JM; Hoch M; Viguier E
Eur J Cancer (1965); 1977; 13(4-5):429-31. PubMed ID: 326556
[No Abstract] [Full Text] [Related]
13. VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas.
Hansen MM; Bloomfield CD; Jørgensen J; Ersbøll J; Pedersen-Bjergaard J; Blom J; Nissen NI
Cancer Treat Rep; 1980; 64(10-11):1135-7. PubMed ID: 7459900
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK
Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285
[TBL] [Abstract][Full Text] [Related]
15. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil].
Qin Y; Shi YK; He XH; Yang JL; Yang S; Yu YX; Li B; Wang QL; Zhou LQ; Sun Y
Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685
[TBL] [Abstract][Full Text] [Related]
16. Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
De Vita VT; Canellos GP; Schein PJ; Chabner BA; Bagley CM; Young RC
Proc Natl Cancer Conf; 1972; 7():379-90. PubMed ID: 4587651
[No Abstract] [Full Text] [Related]
17. [Treatment of large cell lymphoma].
Cohen Y; Epelbaum R; Ben-Shahar M; Haim N; Ron Y
Harefuah; 1989 Dec; 117(12):417-20. PubMed ID: 2695424
[TBL] [Abstract][Full Text] [Related]
18. [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma].
Sampi K; Honda T; Hattori M; Takayama S
Gan To Kagaku Ryoho; 1983 May; 10(5):1266-71. PubMed ID: 6191677
[TBL] [Abstract][Full Text] [Related]
19. Modified MACOP-B chemotherapy for intermediate and high grade non Hodgkins lymphomas.
Gopal R; Nair R; Saikia TK; Soman CS; Dinshaw KA; Advani SH
J Assoc Physicians India; 1994 Oct; 42(10):781-4. PubMed ID: 7533151
[TBL] [Abstract][Full Text] [Related]
20. Non-Hodgkin's lymphomas-present status of chemotherapy.
Young CW
Clin Bull; 1975; 5(1):20-3. PubMed ID: 776444
[No Abstract] [Full Text] [Related]
[Next] [New Search]